Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip, Microfluidics & Microarrays World Congress

Karthik Balakrishnan's Biography



Karthik Balakrishnan, Chief Executive Officer, Nodexus Inc

Dr. Karthik Balakrishnan is the CEO of Nodexus Inc., an Angel- and Venture-backed biotech startup currently housed in the Berkeley Skydeck Accelerator and the QB3 Garage@Berkeley. Nodexus is using exclusively licensed technology developed at the University of California, Berkeley in order to develop a flagship, microfluidics-based label-free multiparametric single cell screening and isolation platform. Dr. Balakrishnan helped develop the Nodexus core technology in graduate school, prior to which he studied Mechanical Engineering at the California Institute of Technology, Pasadena. He has extensive experience in cutting-edge interdisciplinary research involving mechanical engineering, biology, fluidics, circuits, and mathematical modeling and has also been involved in several projects dealing with solving business and technology management problems. Dr. Balakrishnan’s vision is to apply device design and engineering to solve medical problems and to develop commercial solutions to improve patient outcomes.

Karthik Balakrishnan Image

Label-free Multi-parametric Single Cell Screening and Isolation Platform

Monday, 28 September 2015 at 18:15

Add to Calendar ▼2015-09-28 18:15:002015-09-28 19:15:00Europe/LondonLabel-free Multi-parametric Single Cell Screening and Isolation PlatformLab-on-a-Chip, Microfluidics and Microarrays World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Nodexus is commercializing a novel microfluidic platform that is low-cost, portable, and requires minimal sample preparation to provide fast, accurate, multi-parametric results. Using microfluidic cartridge-based modules, we can purify populations from complex samples (e.g. blood) to count, size, characterize, and isolate cells of interest. Because our technology is label-free, there is minimal sample preparation that is needed for testing. Our platform is capable of processing very low sample volumes, such as ~10 µL (particularly crucial in applications where low cell numbers preclude the use of existing technologies) and large volumes (multiple mLs) necessary for rare cell isolation.


Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonLab-on-a-Chip, Microfluidics and Microarrays World CongressLab-on-a-Chip, Microfluidics and Microarrays World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com